Ryszard Swoboda
Publication Activity (10 Years)
Years Active: 2018-2024
Publications (10 Years): 13
Publications (10 Years): 13
Publications
- Arnon Nagler, Myriam Labopin, Ryszard Swoboda, Thomas Schroeder, Rose-Marie Hamladji, Laimonas Griskevicius, Urpu Salmenniemi, Alessandro Rambaldi, Stephan Mielke, Alexander Dmitrievich Kulagin, Jakob R Passweg, Thomas Luft, Tobias Gedde-Dahl, Edouard Forcade, Grzegorz Helbig, Matthias Stelljes, Cristina Castilla-Llorente, Alexandros Spirydonidis, Eolia Brissot, Fabio Ciceri, Florent MalardPost-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone marrow transplantation 59 (7) (2024)
- Arnon Nagler, Myriam Labopin, Ryszard Swoboda, Didier Blaise, Emanuele Angelucci, Jan Vydra, Lucía López Corral, Stefania Bramanti, Patrizia Chiusolo, Mi Kwon, Yener Koc, Maija Itäla-Remes, Massimo Martino, Alexander Kulagin, Alessandro Busca, Fabio Ciceri, Florent MalardYoung (<35 years) haploidentical versus old (≥35 years) mismatched unrelated donors and vice versa for allogeneic stem cell transplantation with post-transplant cyclophosphamide in patients with acute myeloid leukemia in first remission: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone marrow transplantation (2024)
- Arnon Nagler, Myriam Labopin, Ryszard Swoboda, Thomas Schroeder, Rose-Marie Hamladji, Laimonas Griskevicius, Urpu Salmenniemi, Alessandro Rambaldi, Stephan Mielke, Alexander Dmitrievich Kulagin, Jakob R Passweg, Thomas Luft, Tobias Gedde-Dahl, Edouard Forcade, Grzegorz Helbig, Matthias Stelljes, Cristina Castilla-Llorente, Alexandros Spirydonidis, Eolia Brissot, Fabio Ciceri, Florent MalardPost-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone marrow transplantation (2024)
- Arnon Nagler, Myriam Labopin, Ryszard Swoboda, Didier Blaise, Emanuele Angelucci, Jan Vydra, Lucía López Corral, Stefania Bramanti, Patrizia Chiusolo, Mi Kwon, Yener Koc, Maija Itäla-Remes, Massimo Martino, Alexander Kulagin, Alessandro Busca, Fabio Ciceri, Florent MalardYoung (<35 years) haploidentical versus old (≥35 years) mismatched unrelated donors and vice versa for allogeneic stem cell transplantation with post-transplant cyclophosphamide in patients with acute myeloid leukemia in first remission: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone marrow transplantation (2024)
- Arnon Nagler, Myriam Labopin, Ryszard Swoboda, Alexander Dmitrievich Kulagin, Hélène Labussière-Wallet, Montserrat Rovira, Didier Blaise, Jan Vydra, Ibrahim Yakoub Agha, Goda Choi, Péter Reményi, Yener Koc, Jaime Sanz Caballer, Fabio Ciceri, Mohamad MohtyAllogeneic stem cell transplantation for patients with acute myeloid leukemia (AML) in second complete remission (CR2) transplanted from unrelated donors with post-transplant cyclophosphamide (PTCy). A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone marrow transplantation (2023)
- Sebastian Giebel, Myriam Labopin, Thomas Schroeder, Ryszard Swoboda, Johan Maertens, Jean Henri Bourhis, Giovanni Grillo, Urpu Salmenniemi, Inken Hilgendorf, Nicolaus Kröger, Xavier Poire, Jan J Cornelissen, Mutlu Arat, Bipin Savani, Alexandros Spyridonidis, Arnon Nagler, Mohamad MohtyFludarabine versus cyclophospamide in combination with myeloablative total body irradiation as conditioning for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. American journal of hematology 98 (4) (2023)
- Sebastian Giebel, Myriam Labopin, Thomas Schroeder, Ryszard Swoboda, Johan Maertens, Jean Henri Bourhis, Giovanni Grillo, Urpu Salmenniemi, Inken Hilgendorf, Nicolaus Kröger, Xavier Poire, Jan J Cornelissen, Mutlu Arat, Bipin Savani, Alexandros Spyridonidis, Arnon Nagler, Mohamad MohtyFludarabine versus cyclophospamide in combination with myeloablative total body irradiation as conditioning for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. American journal of hematology 98 (4) (2023)
- Arnon Nagler, Myriam Labopin, Ryszard Swoboda, Alexander Dmitrievich Kulagin, Andrea Velardi, Jaime Sanz Caballer, Hélène Labussière-Wallet, Victoria Potter, Jürgen H E Kuball, Simona Sica, Elena Parovichnikova, Wolfgang Andreas Bethge, Natacha Maillard, Uwe Platzbecker, Friedrich Stölzel, Fabio Ciceri, Florent MalardLong-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone marrow transplantation (2023)
- Sebastian Giebel, Myriam Labopin, Thomas Schroeder, Ryszard Swoboda, Johan Maertens, Jean Henri Bourhis, Giovanni Grillo, Urpu Salmenniemi, Inken Hilgendorf, Nicolaus Kröger, Xavier Poire, Jan J Cornelissen, Mutlu Arat, Bipin Savani, Alexandros Spyridonidis, Arnon Nagler, Mohamad MohtyFludarabine versus cyclophospamide in combination with myeloablative total body irradiation as conditioning for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. American journal of hematology 98 (4) (2023)
- Sebastian Giebel, Myriam Labopin, Thomas Schroeder, Ryszard Swoboda, Johan Maertens, Jean Henri Bourhis, Giovanni Grillo, Urpu Salmenniemi, Inken Hilgendorf, Nicolaus Kröger, Xavier Poire, Jan J Cornelissen, Mutlu Arat, Bipin Savani, Alexandros Spyridonidis, Arnon Nagler, Mohamad MohtyFludarabine versus cyclophospamide in combination with myeloablative total body irradiation as conditioning for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. American journal of hematology (2023)
- Ryszard Swoboda, Myriam Labopin, Sebastian Giebel, Thomas Schroeder, Nicolaus M Kröger, Mutlu Arat, Bipin P Savani, Alexandros Spirydonidis, Rose-Marie Hamladji, Victoria Potter, Ana Berceanu, Ibrahim Yakoub Agha, Alessandro Rambaldi, Hakan Ozdogu, Jaime Sanz Caballer, Arnon Nagler, Florent MalardTotal body irradiation plus fludarabine versus busulfan plus fludarabine as a myeloablative conditioning for adults with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study on behalf of the Acute Leukemia Working Party of the EBMT. Bone marrow transplantation (2022)
- Ryszard Swoboda, Myriam Labopin, Sebastian Giebel, Emanuele Angelucci, Mutlu Arat, Mahmoud Aljurf, Simona Sica, Jiri Pavlu, Gerard Sociè, Paolo Bernasconi, Luigi Rigacci, Johanna Tischer, Antonio Maria Risitano, Montserrat Rovira, Riccardo Saccardi, Pietro Pioltelli, Gwendolyn Van Gorkom, Antonin Vitek, Bipin N Savani, Alexandros Spirydonidis, Zinaida Perić, Arnon Nagler, Florent MalardTotal body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMT. Bone marrow transplantation 57 (3) (2022)
- Ryszard Swoboda, Grażyna Kamińska-Winciorek, Magdalena Jaworska, Sebastian Giebel